Müller, Cristina; Vermeulen, Christiaan; Köster, Ulli; Johnston, Karl; Türler, Andreas; Schibli, Roger; van der Meulen, Nicholas P. (2016). Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 5. Springer 10.1186/s41181-016-0008-2
|
Text
art%3A10.1186%2Fs41181-016-0008-2.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (602kB) | Preview |
149Tb represents a powerful alternative to currently used α-emitters: the relatively short half-life (T1/2 = 4.1 h), low α-energy (3.97 MeV, Iα = 16.7 %), absence of α-emitting daughters and stable coordination via DOTA are favorable features for potential clinical application. In this letter, we wish to highlight the unique characteristics of 149Tb for PET imaging, based on its positron emission (Eβ+mean = 730 keV, Iβ+ = 7.1 %) in addition to it’s a therapeutic value. To this end, a preclinical study with a tumor-bearing mouse is presented. The perspective of alpha-PET makes 149Tb highly appealing for radiotheragnostic applications in future clinical trials.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
10 Strategic Research Centers > Albert Einstein Center for Fundamental Physics (AEC) 08 Faculty of Science > Physics Institute > Laboratory for High Energy Physics (LHEP) 08 Faculty of Science > Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP) |
UniBE Contributor: |
Türler, Andreas, Schibli, Roger |
Subjects: |
500 Science > 530 Physics 500 Science > 570 Life sciences; biology 500 Science > 540 Chemistry |
ISSN: |
2365-421X |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Franziska Bornhauser-Rufer |
Date Deposited: |
24 Jan 2017 09:44 |
Last Modified: |
05 Dec 2022 15:01 |
Publisher DOI: |
10.1186/s41181-016-0008-2 |
BORIS DOI: |
10.7892/boris.93777 |
URI: |
https://boris.unibe.ch/id/eprint/93777 |
Actions (login required)
 |
Edit item |